Matrix Capital Management Company, Lp - Net Worth and Insider Trading
Matrix Capital Management Company, Lp Net Worth
The estimated net worth of Matrix Capital Management Company, Lp is at least $50 Million dollars as of 2024-06-04. Matrix Capital Management Company, Lp is the 10% Owner of Aura Biosciences Inc and owns about 6,922,870 shares of Aura Biosciences Inc (AURA) stock worth over $50 Million. Details can be seen in Matrix Capital Management Company, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matrix Capital Management Company, Lp has not made any transactions after 2023-11-09 and currently still holds the listed stock(s).
Transaction Summary of Matrix Capital Management Company, Lp
Matrix Capital Management Company, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matrix Capital Management Company, Lp owns 3 companies in total, including Adaptive Biotechnologies Corp (ADPT) , Zentalis Pharmaceuticals Inc (ZNTL) , and Aura Biosciences Inc (AURA) .
Insider Ownership Summary of Matrix Capital Management Company, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2019-06-26 | director & 10 percent owner & other: See Remarks |
| ZNTL | Zentalis Pharmaceuticals Inc | 2020-04-03 | director & 10 percent owner & other: See Remarks |
| AURA | Aura Biosciences Inc | 2023-11-09 | 10 percent owner |
Matrix Capital Management Company, Lp Latest Holdings Summary
Matrix Capital Management Company, Lp currently owns a total of 1 stock. Matrix Capital Management Company, Lp owns 6,922,870 shares of Aura Biosciences Inc (AURA) as of November 9, 2023, with a value of $50 Million.
Latest Holdings of Matrix Capital Management Company, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AURA | Aura Biosciences Inc | 2023-11-09 | 6,922,870 | 7.16 | 49,567,749 |
Holding Weightings of Matrix Capital Management Company, Lp
Matrix Capital Management Company, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Matrix Capital Management Company, Lp has made a total of 3 transactions in Aura Biosciences Inc (AURA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Aura Biosciences Inc is the acquisition of 1,560,000 shares on November 9, 2023, which cost Matrix Capital Management Company, Lp around $14 Million.
Insider Trading History of Matrix Capital Management Company, Lp
- 1
Matrix Capital Management Company, Lp Trading Performance
GuruFocus tracks the stock performance after each of Matrix Capital Management Company, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matrix Capital Management Company, Lp is 2.99%. GuruFocus also compares Matrix Capital Management Company, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matrix Capital Management Company, Lp within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matrix Capital Management Company, Lp's insider trading performs compared to the benchmark.
Performance of Matrix Capital Management Company, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.54 | | | | | |
| Relative Return to S&P 500(%) | 6.54 | | | | | |
Matrix Capital Management Company, Lp Ownership Network
Matrix Capital Management Company, Lp Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Matrix Capital Management Company, Lp is the director & 10 percent owner & other: See Remarks of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Chief Commercial Ofc Imm Med Sharon Benzeno , Chief Financial Officer Tycho Peterson , and Principal Accounting Officer Kyle Piskel .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Matrix Capital Management Company, Lp made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 29,934 shares made by R Mark Adams , and a net sale of 11,515 shares made by Kyle Piskel .
In summary, during the past 3 months, insiders sold 181,388 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 181,388 shares. During the past 18 months, 553,199 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 553,199 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Matrix Capital Management Company, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Matrix Capital Management Company, Lp. You might contact Matrix Capital Management Company, Lp via mailing address: 1000 Winter Street, C/o Matrix Capital Management, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
